| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 2.294 | - | - | - | 18.437 | 18.690 | 25.031 | 25.568 | 113.928 |
| Total Income - EUR | 0 | 2.294 | - | - | - | 18.438 | 18.690 | 25.032 | 25.568 | 113.929 |
| Total Expenses - EUR | 27 | 415 | - | - | - | 5.934 | 9.637 | 9.530 | 24.741 | 79.702 |
| Gross Profit/Loss - EUR | -27 | 1.879 | - | - | - | 12.504 | 9.053 | 15.502 | 828 | 34.227 |
| Net Profit/Loss - EUR | -27 | 1.811 | - | - | - | 12.319 | 8.866 | 15.232 | 572 | 31.582 |
| Employees | 0 | 0 | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - G.i. Medart S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 84 | 0 | - | - | - | 0 | 0 | 1.552 | 598 | 22.901 |
| Current Assets | 47 | 2.350 | - | - | - | 39.976 | 18.866 | 23.481 | 26.780 | 53.301 |
| Inventories | 0 | 0 | - | - | - | 0 | 0 | 0 | 66 | 1.487 |
| Receivables | 0 | 0 | - | - | - | 0 | 1.058 | 2.940 | 15.595 | 38.665 |
| Cash | 47 | 2.350 | - | - | - | 39.976 | 17.807 | 20.541 | 11.119 | 13.149 |
| Shareholders Funds | 18 | 1.828 | - | - | - | 32.185 | 8.893 | 24.153 | 24.652 | 49.835 |
| Social Capital | 45 | 45 | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 112 | 522 | - | - | - | 7.791 | 9.973 | 881 | 2.726 | 26.368 |
| Income in Advance | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - G.i. Medart S.r.l.